Outcome of patients with microscopic and macroscopic metastatic nodal merkel cell carcinoma: An Australian experience

Dermatologic Surgery

Volumn 40, Issue 1, 2014, Pages 46-51

  Howle, Julie R ^a,b,c   Veness, Michael J ^a,b,c  

^a WESTMEAD HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LARGE CELL LYMPHOMA; LIMB TUMOR; LYMPHATIC LEUKEMIA; MACROSCOPIC NODAL METASTASIS; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; MICROSCOPIC NODAL METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE METASTASIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR VOLUME; ADJUVANT THERAPY; COMPARATIVE STUDY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

ADULT; AGED; CARCINOMA, MERKEL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEW SOUTH WALES; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84897019152     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12390     Document Type: Article

References (24)

1. Toker C,. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105: 107-10.
2. Surveillance, Epidemiology and End Results (SEER). Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 1975-2005. Available from: http://seer.cancer.gov/csr/1975-2005.
3. Agelli M, Limin XC,. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49: 832-41.
4. Penn I, First MR,. Merkel cell carcinoma in organ transplant recipients: report of 41 cases. Transplantation 1999; 68: 1717-21.
5. Koljonen V, Kukko H, Pukkala E, Sankila R, et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 2009; 101: 1444-7.
6. Engels EA, Frisch M, Goedart J, Biggar R, et al. Merkel cell carcinoma and HIV infection. Lancet 2002; 359: 497-8.
7. Feng H, Shuda M, Chang Y, Moore P,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100.
8. Amber K, McLeod MP, Nouri K,. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma. Dermatol Surg 2013; 39: 232-8.
9. Lemos B, Storer B, Iyer J, Phillips J, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010; 63: 751-61.
10. Howle J, Veness M,. Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead hospital experience. Australas J Dermatol 2012; 53: 26-31.
11. Mehrany K, Otley C, Weenig R, Phillips P, et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002; 28: 113-7.
12. Schwartz J, Bichakjian C, Lowe L, Griffith K, et al. Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort. Dermatol Surg 2013; 39: 1009-16.
13. Fields R, Busam K, Chou J, Panageas K, et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg 2011; 254: 465-75.
14. Lim C, Whalley D, Haydu L, Murali R, et al. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma. Ann Surg Oncol 2012; 19: 3325-34.
15. Fields R, Busam K, Chou J, Panageas K, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011; 18: 2529-37.
16. Bajetta E, Celio L, Platania M, Lo Vullo S, et al. Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann Surg Oncol 2009; 16: 2985-93.
17. Smith V, Camp R, Lentsch E,. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data. Laryngoscope 2012; 122: 1283-90.
18. Veness M, Morgan G, Gebski V,. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 2005; 27: 208-16.
19. Howle JR, Hughes TM, Gebski V, Veness M,. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. J Am Acad Dermatol 2012; 67: 33-40.
20. Lewis K, Weinstock M, Weaver A, Ottley C, et al. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006; 142: 693-700.
21. Foote M, Veness M, Zarate D, Poulsen M,. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease. J Am Acad Dermatol 2012; 67: 395-9.
22. Tarantola T, Vallow L, Halyard M, Weenig R, et al. Unknown primary Merkel cell carcinoma: 23 new cases and a review. J Am Acad Dermatol 2013; 68: 433-40.
23. Fang C, Lemos B, Douglas J, Iyer J, et al. Radiation monotherapy as regional treatment for lymph node positive Merkel cell carcinoma. Cancer 2010; 116: 1783-90.
24. Miller NJ, Bhatia S, Parvathaneni U, Iyer J, et al. Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma. Curr Treat Options Oncol 2013; 14: 249-63.